2Anderson H,Lund B,Bach F,et al.Single-agent activity of weekly Gemcitabine in advanced non-small-cell lung cancer:A phase II study[J].Clin Oncol,1994,12 (9):1 821-1 826.
3E Vokes E.Trends and perspectives in multimodality therapy of locoregionally advanced non-small cell lung cancer[J].Lung Cancer,2001,33 (Suppl 1):S85-S89.
4Noble S,Goa KL.Gemcitabine,a review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer[J].Drugs,1997,54(3):447-472.
5Choy H.Combination chemoradiotherapy with Gemcitabine:potential applications[J].Oncology (Huntingt),2000,14(7 Suppl 4):20-25.
6Cesario A,Margaritora S,Trodella L,et al.Incidental surgical findings of a phaseⅠtrial of weekly Gemcitabine and concurrent radiotherapy in patients with unresectable non-small cell lung cancer J[J].Lung Cancer,2002,37(2):207-212.
7Mason KA,Milas L,Hunter NR,et al.Maximizing therapeutic gain with Gemcitabine and fractionated radiation[J].Int J Radiat Oncol BiolPhys,1999,44(5):1 125-1 135.
8陈东福等著,殷蔚伯,谷铣之.肿瘤放射治疗学[M]中国协和医科大学出版社,2002.
9Allen AM,Zalupski MM,Robertson JM,et al.Adjuvant therapyin pancreatic cancer:PhaseⅠtrial of radiation dose escalationwith concurrent full-dose gemcitabine. International Journal of Radiation Oncology Biology Physics . 2004
10Ito Y,Okusaka T,Kagmi Y,et al.Evaluation of acute intestinaltoxicity in relation to the volume of irradiated small bowel in pa-tients treated with concurrent weekly gemcitabine and radiothera-py for locally advanced pancreatic cancer. Anticancer Research . 2006
